Skip to main content
logo
Pliant Therapeutics, Inc. (PLRX)
NASDAQ: PLRX · Real-Time Price · USD
1.130
0.00 (0.00%)
At close: Jun 25, 2026, 4:00 PM EDT
1.121
-0.009 (-0.76%)
After-hours: Jun 25, 2026, 7:32 PM EDT

Pliant Therapeutics Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
---1.589.697.57
Revenue Growth (YoY)
----83.69%27.91%-81.89%
Gross Profit
---1.589.697.57
Selling, General & Admin
39.9147.2259.0657.9339.9527.56
Research & Development
79.31109.16169.31127.896.9477.55
Total Operating Expenses
119.21156.37228.37185.73136.89105.11
Operating Income
-119.21-156.37-228.37-184.15-127.2-97.54
Interest Expense
-1.76-2.56-3.02-1.27-0.79-
Other Non-Operating Income (Expense)
9.589.5921.0924.084.670.27
Total Non-Operating Income (Expense)
7.827.0318.0622.813.880.27
Pretax Income
-111.39-149.34-210.3-161.34-123.32-97.26
Net Income
-113.22-149.34-210.3-161.34-123.32-97.26
Net Income to Common
-113.22-149.34-210.3-161.34-123.32-97.26
Shares Outstanding (Basic)
626161594236
Shares Outstanding (Diluted)
626161594236
Shares Change (YoY)
1.17%1.37%3.10%39.75%17.21%67.94%
EPS (Basic)
-1.84-2.43-3.47-2.75-2.94-2.71
EPS (Diluted)
-1.84-2.43-3.47-2.75-2.94-2.71
Free Cash Flow
-98.81-128.71-159.35-117.28-96.39-77.4
Free Cash Flow Per Share
-1.61-2.10-2.63-2.00-2.29-2.16
Gross Margin
---100.00%100.00%100.00%
Operating Margin
----11654.70%-1313.37%-1288.10%
Profit Margin
----10211.10%-1273.32%-1284.51%
FCF Margin
----7422.91%-995.26%-1022.13%
EBITDA
-117.7-154.68-226.24-182.3-125.38-96
EBITDA Margin
----11538.20%-1294.55%-1267.83%
EBIT
-119.21-156.37-228.37-184.15-127.2-97.54
EBIT Margin
----11654.70%-1313.37%-1288.10%
SEC Filings: 10-K · 10-Q